Jun Okabe

9PUBLICATIONS
44CO-AUTHORS
Major global burdens of diseasePredictive and prognostic markersCharacterisation of biological macromoleculesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Pharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|May 29, 2026
EZH2 inhibition via GSK-126 mitigates EndMT and atherosclerosis in diabetes: A translational epigenetic approach.

|May 04, 2026
Ubiquitin-Specific Protease 2 (USP2) as a Modulator of Energy Metabolism: A Review of Studies Using Animal and Cellular Models.

|Jan 23, 2024
Potential of Modulating Aldosterone Signaling and Mineralocorticoid Receptor with microRNAs to Attenuate Diabetic Kidney Disease.

Shinji Hagiwara, Tomohito Gohda, Phillip Kantharidis

|Jul 21, 2022
Inhibition of pancreatic EZH2 restores progenitor insulin in T1D donor.

Keith Al-Hasani, Ishant Khurana, Lina Mariana

|Mar 21, 2021
Epigenetic evidence of an Ac/Dc axis by VPA and SAHA.

Sebastian Lunke, Scott Maxwell, Ishant Khurana

|Nov 16, 2017
Ubiquitin-Specific Protease 2 Modulates the Lipopolysaccharide-Elicited Expression of Proinflammatory Cytokines in Macrophage-like HL-60 Cells.

Hiroshi Kitamura, Takeshi Ishino, Yoshinori Shimamoto

Pageof 2

Frequent Collaborators

5 joint publications

Scott Maxwell

3 joint publications

Ishant Khurana

3 joint publications

Harikrishnan Kaipananickal

3 joint publications

Keith Al-Hasani